Drug Profile
Research programme: infectious disease vaccine - LG Chem
Alternative Names: LBVDLatest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator LG Life Sciences
- Developer LG Chem
- Class Bacterial vaccines; Viral vaccines
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bacterial meningitis; Diphtheria; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for research development in Bacterial-meningitis in South Korea
- 28 Oct 2019 No recent reports of development identified for research development in Diphtheria in South Korea
- 28 Oct 2019 No recent reports of development identified for research development in Hepatitis-B in South Korea